ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 109 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.92 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,223 | -62.9% | 110,817 | -47.8% | 0.00% | -75.0% |
| Q2 2023 | $5,993 | +287.4% | 212,415 | +136.1% | 0.00% | +300.0% |
| Q1 2023 | $1,547 | -39.9% | 89,964 | -29.6% | 0.00% | 0.0% |
| Q4 2022 | $2,576 | -99.9% | 127,874 | +9.7% | 0.00% | -66.7% |
| Q3 2022 | $2,526,000 | +2504.1% | 116,598 | +3284.6% | 0.00% | – |
| Q2 2022 | $97,000 | -69.3% | 3,445 | -49.7% | 0.00% | – |
| Q1 2022 | $316,000 | – | 6,854 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 2,099,583 | $42,117,635 | 14.06% |
| Mayo Clinic | 187,143 | $3,754,089 | 7.23% |
| Matrix Capital Management Company, LP | 13,959,973 | $280,037,058 | 3.36% |
| 5AM Venture Management, LLC | 490,000 | $9,829,400 | 2.83% |
| Eventide Asset Management | 7,814,039 | $156,749,622 | 2.82% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 961,486 | $19,287,410 | 2.70% |
| Avidity Partners Management LP | 2,100,000 | $42,126,000 | 1.70% |
| First Light Asset Management, LLC | 848,477 | $17,020,449 | 1.62% |
| Sofinnova Investments, Inc. | 1,211,641 | $24,305,518 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 386,525 | $7,753,692 | 1.51% |